Is Abeona Therapeutics (ABEO) Inc a good buy right now?

ABEO

Abeona Therapeutics Inc is a preliminary-stage biopharmaceutical organization, which takes part in the advancement of quality treatment for extreme and dangerous intriguing sicknesses. The firm operated in the healthcare sector. The market capitalization of ABEO is $36.73 million and has its headquarters in New York. The stock of Abeona Therapeutics trades under the symbol of […]

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.